New drug trial targets Cancer's genetic weakness
NCT ID NCT06400238
Summary
This study is testing whether a drug called copanlisib can help control advanced cancers that have a specific change in a gene called PTEN. The drug is given through an IV and aims to block signals that tell cancer cells to grow. It is for adults with various advanced or hard-to-treat cancers, including solid tumors, lymphoma, and multiple myeloma, who have this specific genetic feature.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ECOG-ACRIN Cancer Research Group
Philadelphia, Pennsylvania, 19103, United States
Conditions
Explore the condition pages connected to this study.